Is There Now an Opportunity in Fuchs as Shares Trade 36% Below Cash Flow Value?

If you are wondering whether it is time to buy, hold, or part ways with your Fuchs shares, you are definitely not alone. The stock’s performance has caught some attention recently, with curious upswings and a bit of volatility sprinkled in. In the past week, Fuchs posted a modest 0.8% gain, even as its 30-day return softened to -2.8%. Looking at the bigger picture, there is a reassuring 5.7% bump over the last year, and a striking 64.0% rise over the past three years. While this long-term growth is promising, results over five years have moderated to a still respectable 12.1%, perhaps reflecting changing expectations or a shift in how the market values stable, mature businesses.

Many investors are paying close attention after recent market developments, as shifts in global demand and supply chains could either expand or dent Fuchs’ appeal going forward. With a last close at 40.06, there is solid evidence that the company is drawing renewed interest, suggesting both growth potential and some fresh reassessment around risk.

On that note, here’s something concrete: Fuchs earns a robust valuation score of 5 out of a possible 6, given that it is undervalued in five key checks. This already sounds like a winning hand, but as any savvy investor knows, the real challenge is figuring out what actually makes a stock genuinely undervalued or a value trap in disguise.

Next, let’s break down the common approaches to valuation, highlighting how Fuchs stacks up in each category. Stay tuned, because there is an even smarter, holistic way to approach valuation that can give you the edge. More on that at the end of the article.

Fuchs delivered 5.7% returns over the last year. See how this stacks up to the rest of the Chemicals industry.

Approach 1: Fuchs Discounted Cash Flow (DCF) Analysis

The Discounted Cash Flow (DCF) model works by projecting a company’s future free cash flows and then discounting them back to today’s value to assess how much the entire business is worth in present terms. For Fuchs, this approach uses the 2 Stage Free Cash Flow to Equity model, and all cash flows are reported in euros (€).

Currently, Fuchs generates a Last Twelve Months Free Cash Flow of €324.6 million. Analysts forecast modest growth in annual free cash flow, with projections showing €321.96 million by 2027. Projections further estimate the company could generate approximately €360 million in free cash flow by 2035. For years beyond direct analyst coverage, these numbers are extrapolated based on long-term growth trends.

Based on these forecasts, the DCF model estimates Fuchs’ fair value per share at €62.66. With the current share price last closing at €40.06, this implies the stock is trading at a 36.1% discount to its intrinsic value according to this model. In this context, the market appears to be underestimating Fuchs’ true long-term cash generation potential.

Result: UNDERVALUED

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Fuchs.

Our Discounted Cash Flow (DCF) analysis suggests Fuchs is undervalued by 36.1%. Track this in your watchlist or portfolio, or discover more undervalued stocks.

Approach 2: Fuchs Price vs Earnings (PE Ratio)

For established, profitable companies like Fuchs, the price-to-earnings (PE) ratio is often considered the go-to benchmark for valuation. The PE ratio measures how much investors are willing to pay today for each euro of current earnings. This makes it a useful way to gauge market sentiment around the company’s profitability and growth prospects.

A company’s ideal or “fair” PE ratio is shaped by more than just its earnings. If investors expect strong earnings growth, a higher PE can be justified. Increased risks or stagnant performance typically result in a lower PE. It is also routine to check how a company’s PE compares to its industry peers and the sector as a whole, but this only tells part of the story.

As things stand, Fuchs trades on a PE ratio of 18.0x. That is below both the Chemicals industry average of 22.6x and the peer group average of 20.9x. However, these raw comparisons have their limits. This is where Simply Wall St’s proprietary “Fair Ratio” comes in. By factoring in the company’s growth, risk profile, market cap, profit margins, and sector, the Fair Ratio offers a more dynamic yardstick. For Fuchs, the Fair Ratio works out to 17.2x, suggesting that the market price closely mirrors what would be expected based on underlying fundamentals.

In summary, Fuchs’ current PE ratio is almost the same as its Fair Ratio. That means the stock is about right priced based on this multiple.

Result: ABOUT RIGHT

PE ratios tell one story, but what if the real opportunity lies elsewhere? Discover companies where insiders are betting big on explosive growth.

Upgrade Your Decision Making: Choose your Fuchs Narrative

Earlier we mentioned that there is an even better way to understand valuation, so let’s introduce you to Narratives. Narratives are simply your story about a company, providing a way to combine your view on Fuchs’ business future with numbers like fair value, and expectations for revenue, earnings, and profit margins.

Instead of relying on a single estimate, Narratives let you connect what you believe about Fuchs, such as rapid growth in EV lubricants or pressure from weak macro conditions, directly to your financial forecast and resulting valuation. This means your investment decision becomes more personal, dynamic, and reflective of what you know and observe.

Using Simply Wall St’s Community page, Narratives are easy to create and compare. They help millions of investors visualize how different assumptions lead to different fair values and buy/sell opportunities. Narratives are automatically updated when new financial results or market events occur, keeping your viewpoint relevant and actionable.

For example, one investor might craft a Narrative based on high expected earnings and a fair value of €56.0, while another may see ongoing risks and land on €39.0. This demonstrates how much perspectives can differ even on the same stock.

Do you think there's more to the story for Fuchs? Create your own Narrative to let the Community know!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com